Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jose Romero

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Infectious Diseases
Address ACH Sturgis Building
800 Marshall Street
Mail Slot # 512-11
Little Rock AR 72202
Phone501-364-1416
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01AG059725     (ROMERO, JOSE RAFAEL)Aug 1, 2019 - Apr 30, 2024
    NIH
    Enlarged Perivascular Spaces as Markers of Vascular and Alzheimer pathology: predictors, pathophysiology and clinical consequences
    Role: Principal Investigator

    UL1TR003107     (JAMES, LAURA P)Jul 1, 2019 - Jun 30, 2024
    NIH
    Expanding Translational Research in Arkansas
    Role: Co-Investigator

    R21CA231180     (TEETER, BENJAMIN SAMUEL)Apr 1, 2019 - Mar 31, 2021
    NIH
    Improving HPV Vaccination using Implementation Strategies in Community Pharmacies
    Role: Co-Investigator

    U54TR001629     (JAMES, LAURA P)Sep 26, 2017 - Aug 31, 2019
    NIH
    Expanding Translational Research in Arkansas
    Role: Co-Investigator

    R03AG048180     (ROMERO, JOSE RAFAEL)Jun 1, 2015 - May 31, 2018
    NIH
    Cerebral Microbleeds in Young Adults: risk factors, biomarkers and genetics
    Role: Principal Investigator

    K23AG038444     (ROMERO, JOSE RAFAEL)Aug 15, 2011 - May 31, 2017
    NIH
    Risk Factors, Genetics and Cognition in Cerebral Microbleeds: Framingham Study
    Role: Principal Investigator

    R01HL096518     (ROMERO, JOSE R)Apr 25, 2009 - Mar 31, 2014
    NIH/NHLBI
    Aldosteron, Intracellular Leukocyte Magnesium and Inflammation in Diabetes
    Role: Principal Investigator

    R21ES014462     (ROMERO, JOSE R)Jan 25, 2006 - Nov 30, 2008
    NIH/NIEHS
    Disruption of the Myofibroblast Phenotype by Flavonoids
    Role: Principal Investigator

    R03DK064841     (ROMERO, JOSE R)Sep 20, 2003 - Aug 31, 2007
    NIH/NIDDK
    CELLULAR MAGNESIUM DYSFUNCTION IN DIABETES
    Role: Principal Investigator

    K01DK002817     (ROMERO, JOSE R)Sep 30, 2000 - Jun 30, 2004
    NIH/NIDDK
    INSULIN REGULATED NA+ AND CA2+ TRANSPORT IN HYPERTENSION
    Role: Principal Investigator

    R03DK053538     (ROMERO, JOSE R)May 1, 1998 - Sep 29, 2000
    NIH/NIDDK
    LYMPHOCYTE CYTOSOLIC CALCIUM IN HYPERTENSION
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Petrie BK, Sturzoiu T, Shulman J, Abbas S, Masoud H, Romero JR, Filina T, Nguyen TN, Lau H, Clark J, Auerbach S, Pyatkevich YG, Aparicio HJ. Questionnaire and Portable Sleep Test Screening of Sleep Disordered Breathing in Acute Stroke and TIA. J Clin Med. 2021 Aug 13; 10(16). PMID: 34441863.
      View in: PubMed
    2. Carneiro T, Dashkoff J, Leung L, Nobleza COS, Marulanda-Londono E, Hathidara M, Koch S, Sur N, Boske A, Voetsch B, Daneshmand A, Shulman J, Curiale G, Greer DM, Romero JR, Anand P, Cervantes-Arslanian AM. Response to the Letter to the Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19. J Stroke Cerebrovasc Dis. 2021 07; 30(7):105789. PMID: 33840594.
      View in: PubMed
    3. Lioutas VA, Ivan CS, Himali JJ, Aparicio HJ, Leveille T, Romero JR, Beiser AS, Seshadri S. Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke. JAMA. 2021 01 26; 325(4):373-381. PMID: 33496774.
      View in: PubMed
    4. Baril AA, Beiser AS, Mysliwiec V, Sanchez E, DeCarli CS, Redline S, Gottlieb DJ, Maillard P, Romero JR, Satizabal CL, Zucker JM, Seshadri S, Pase MP, Himali JJ. Slow-Wave Sleep and MRI Markers of Brain Aging in a Community-Based Sample. Neurology. 2021 03 09; 96(10):e1462-e1469. PMID: 33361258.
      View in: PubMed
    5. Ortega-Gutierrez S, Farooqui M, Zha A, Czap A, Sebaugh J, Desai S, Jadhav A, Vora N, Rai V, Jovin TG, Thon JM, Heslin M, Thau L, Zevallos C, Quispe-Orozco D, Jillella DV, Nahab F, Mohammaden MH, Nogueira RG, Haussen DC, Nguyen TN, Romero JR, Aparicio HJ, Osman M, Haq IU, Liebeskind D, Hassan AE, Zaidat O, Siegler JE. Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: The Society of Vascular and Interventional Neurology Multicenter Collaboration. Clin Neurol Neurosurg. 2021 02; 201:106436. PMID: 33383463.
      View in: PubMed
    6. Katsanos AH, Lioutas VA, Charidimou A, Catanese L, Ng KKH, Perera K, de Sa Boasquevisque D, Falcone GJ, Sheth KN, Romero JR, Tsivgoulis G, Smith EE, Sharma M, Selim MH, Shoamanesh A. Statin treatment and cerebral microbleeds: A systematic review and meta-analysis. J Neurol Sci. 2021 01 15; 420:117224. PMID: 33183779.
      View in: PubMed
    7. Lioutas VA, Beiser AS, Aparicio HJ, Himali JJ, Selim MH, Romero JR, Seshadri S. Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016. JAMA Neurol. 2020 10 01; 77(10):1252-1260. PMID: 32511690.
      View in: PubMed
    8. Petrea RE, O'Donnell A, Beiser AS, Habes M, Aparicio H, DeCarli C, Seshadri S, Romero JR. Mid to Late Life Hypertension Trends and Cerebral Small Vessel Disease in the Framingham Heart Study. Hypertension. 2020 09; 76(3):707-714. PMID: 32755403.
      View in: PubMed
    9. Carneiro T, Dashkoff J, Leung LY, Nobleza COS, Marulanda-Londono E, Hathidara M, Koch S, Sur N, Boske A, Voetsch B, Aboul Nour H, Miller DJ, Daneshmand A, Shulman J, Curiale G, Greer DM, Romero JR, Anand P, Cervantes-Arslanian AM. Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19. J Stroke Cerebrovasc Dis. 2020 Nov; 29(11):105201. PMID: 33066885.
      View in: PubMed
    10. Ford T, Curiale G, Nguyen TN, Aparicio H, Hamlyn EK, Gangadhara S, Cervantes-Arslanian AM, Greer D, Romero JR, Shulman JG. Optimization of resources and modifications in acute ischemic stroke care in response to the global COVID-19 pandemic. J Stroke Cerebrovasc Dis. 2020 Aug; 29(8):104980. PMID: 32689645.
      View in: PubMed
    11. Charidimou A, Frosch MP, Al-Shahi Salman R, Baron JC, Cordonnier C, Hernandez-Guillamon M, Linn J, Raposo N, Rodrigues M, Romero JR, Schneider JA, Schreiber S, Smith EE, van Buchem MA, Viswanathan A, Wollenweber FA, Werring DJ, Greenberg SM. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int J Stroke. 2019 12; 14(9):956-971. PMID: 31514686.
      View in: PubMed
    12. Pase MP, Himali JJ, Aparicio HJ, Romero JR, Satizabal CL, Maillard P, DeCarli C, Beiser AS, Seshadri S. Plasma total-tau as a biomarker of stroke risk in the community. Ann Neurol. 2019 09; 86(3):463-467. PMID: 31271449.
      View in: PubMed
    13. Teeter BS, Mosley C, Thomas JL, Martin B, Jones D, Romero JR, Curran GM. Improving HPV vaccination using implementation strategies in community pharmacies: Pilot study protocol. Res Social Adm Pharm. 2020 03; 16(3):336-341. PMID: 31174950.
      View in: PubMed
    14. Smith EE, Biessels GJ, De Guio F, de Leeuw FE, Duchesne S, Düring M, Frayne R, Ikram MA, Jouvent E, MacIntosh BJ, Thrippleton MJ, Vernooij MW, Adams H, Backes WH, Ballerini L, Black SE, Chen C, Corriveau R, DeCarli C, Greenberg SM, Gurol ME, Ingrisch M, Job D, Lam BYK, Launer LJ, Linn J, McCreary CR, Mok VCT, Pantoni L, Pike GB, Ramirez J, Reijmer YD, Romero JR, Ropele S, Rost NS, Sachdev PS, Scott CJM, Seshadri S, Sharma M, Sourbron S, Steketee RME, Swartz RH, van Oostenbrugge R, van Osch M, van Rooden S, Viswanathan A, Werring D, Dichgans M, Wardlaw JM. Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration. Alzheimers Dement (Amst). 2019 Dec; 11:191-204. PMID: 30859119.
      View in: PubMed
    15. Smith EE, Romero JR. Mixed emotions: What to do with patients who have lobar and deep hemorrhages on MRI? Neurology. 2018 01 09; 90(2):55-56. PMID: 29247077.
      View in: PubMed
    16. Olarte L, Romero J, Barson W, Bradley J, Lin PL, Givner L, Tan T, Hoffman J, Hultén KG, Mason EO, Kaplan SL. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204. PMID: 28723870.
      View in: PubMed
    17. Lioutas VA, Beiser A, Himali J, Aparicio H, Romero JR, DeCarli C, Seshadri S. Lacunar Infarcts and Intracerebral Hemorrhage Differences: A Nested Case-Control Analysis in the FHS (Framingham Heart Study). Stroke. 2017 02; 48(2):486-489. PMID: 28008091.
      View in: PubMed
    18. Saber H, Himali JJ, Shoamanesh A, Beiser A, Pikula A, Harris TB, Roubenoff R, Romero JR, Kase CS, Vasan RS, Seshadri S. Serum Leptin Levels and the Risk of Stroke: The Framingham Study. Stroke. 2015 Oct; 46(10):2881-5. PMID: 26337973.
      View in: PubMed
    19. Martinez-Ramirez S, Romero JR, Shoamanesh A, McKee AC, Van Etten E, Pontes-Neto O, Macklin EA, Ayres A, Auriel E, Himali JJ, Beiser AS, DeCarli C, Stein TD, Alvarez VE, Frosch MP, Rosand J, Greenberg SM, Gurol ME, Seshadri S, Viswanathan A. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement. 2015 Dec; 11(12):1480-1488. PMID: 26079413.
      View in: PubMed
    20. Arthur C, Tang X, Romero JR, Gossett JG, Harik N, Prodhan P. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience. Pediatr Cardiol. 2015 Mar; 36(3):509-15. PMID: 25293429.
      View in: PubMed
    21. Demissie DE, Kaplan SL, Romero JR, Leake JA, Barson WJ, Halasa NB, Byington CL, Shetty AK, Tan TQ, Hoffman JA, Lin PL, Edwards KM, Mason EO, Cooperstock MS. Altered neutrophil counts at diagnosis of invasive meningococcal infection in children. Pediatr Infect Dis J. 2013 Oct; 32(10):1070-2. PMID: 23736141.
      View in: PubMed
    22. Romero JR, Modlin J. Principles and Practice of Infectious Diseases. Coxsackieviruses. 2013.
    23. Romero JR. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. West Nile Virus. 2013.
    24. Hulten KG, Kaplan SL, Lamberth LB, Barson WJ, Romero JR, Lin PL, Bradley JS, Givner LB, Tan TQ, Hoffman JA, Mason EO. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013; 51:1294-1297.
    25. Romero JR, Modlin J. Principles and Practice of Infectious Diseases. Introduction to the Human Enteroviruses and Parechoviruses. 2013.
    26. Martin K, Romero JR. Comprehensive Pediatric Hospital Medicine. Central Nervous System Infections. 2013.
    27. Romero JR, Jacobs RF. Textbook of Pediatric Infectious Diseases. Fungal Meningitis. 2013.
    28. Romero JR, Modlin J. Principles and Practice of Infectious Diseases. Polioviruses. 2013.
    29. Stellrecht KA, Lamson DA, Romero JR. Manual of Clinical Microbiology. Entroviruses and parechoviruses. 2013.
    30. Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013; 32:203-207.
    31. Romero JR. Infections of the Central Nervous System. Viral Meningitis and Aseptic Meningitis. 2013.
    32. Romero JR, Modlin J. Principles and Practice of Infection Diseases. Parechoviruses. 2013.
    33. Martin K, Romero JR. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. St. Louis Encephalitis. 2013.
    34. Wheeler JG, Romero JR. Tick-related illnesses in Arkansas: myths and management. J Ark Med Soc. 2012 May; 108(12):272-3. PMID: 22679681.
      View in: PubMed
    35. Romero J. Enteroviruses in Humans. 2012.
    36. Linam WM, Gilliam CH, Honeycutt MD, Wisdom CM, Swearingen CJ, Romero JR. Parental Perceptions about Mandatory Influenza Immunization of Pediatric Healthcare Workers. Pediatric Academic Societies' Meeting. 2012.
    37. Kaplan SL, Barson, W, Lin, P, Romero JR, Bradley, J, Tan, T, Hoffman, J. Early Trends for Invasive Pneumococcal Infections in Children Following the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine. 49th Annual Meeting of the Infectious Diseases Society of America. 2012.
    38. McKee SG, Linam WM, Romero JR. Methicillin-resistant Staphylococcus aureus epidural abscesses in children. J Investigative Med. 2012; 40.
    39. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Diseases : 49 clinical questions. What Is the Best Empiric and/or Prophylactic Therapy for a Child in Whom You Suspect a Tick-borne Infection?. 2012.
    40. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Diseases : 49 clinical questions. What Are the Best Prophylactic Measures to Tell Families to Use to Prevent Tick Bites? At What Age Are Agents Such as DEET and Picaridin Safe to Use?. 2012.
    41. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Diseases : 49 clinical questions. In What Part of the United States is Lyme Disease Seen, How is Diagnosis Confirmed, and What is the Appropriate Treatment?. 2012.
    42. Demissie DE, Kaplan SL, Romero JR, Leake JAD, Barson WJ, Halasa NB, Byington CL, Shetty AK, Tan TQ, Hoffman JA, Lin PL, Edwards KM, Mason EO, Cooperstock MS. Neutrophil Profile at Diagnosis of Invasive Meningococcal Infection in Chil. Pediatric Academic Societies' Meeting. 2012.
    43. Bell J, Anderson EJ, Greene WH, Romero JR, Merchant M, Selvarangan R. A Multicentered evaluation of the performance characteristics of the BD Veritor System for rapid RSV detection. 50th Annual Meeting of the Infectious Diseases Society of America. 2012.
    44. Romero JR. Principles and Practice of Pediatric Infectious Diseases. 292-297. 2012; 43.
    45. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Disease: 49 clinical questions. When Are Tick-borne Infections Typically Seen in the United States, and When Does the Peak Time Occur?. 2012.
    46. Petrea RE, Koyfman F, Pikula A, Romero JR, Viereck J, Babikian VL, Kase CS, Nguyen TN. Acute stroke, catheter related venous thrombosis, and paradoxical cerebral embolism: report of two cases. J Neuroimaging. 2013 Jan; 23(1):111-4. PMID: 21281383.
      View in: PubMed
    47. Romero JR, Rothbart HA, Nyquist AC, Nolte F. Enteroviral Meningitis Does Not Exclude Concurrent Bacterial Meningitis, Authors’ Reply. J Clin Micro. 2011; 49:3440-3441.
    48. Romero J. Rudolph's Pediatrics. Enteroviruses. 2011.
    49. Romero JR, Selvarangan R. The human Parechoviruses: an overview. Adv Pediatr. 2011; 58(1):65-85. PMID: 21736976.
      View in: PubMed
    50. Romero JR. Cecil Medicine. Enteroviruses (Poliovirus, Coxsakieviruses, Echoviruses, and Others). 2011.
    51. Sanders RC, Diokno RM, Romero JR. MRSA Infections in Children. J AR Med Soc. 2011; 107:287-290.
    52. Nolte FS, Tang YW, Robinson CC, Rogers B, Kehl KS, Rand KH, Oberste MS, Rotbart HA, Romero JR, Nyquist AC, Persing DH. Evaluation of a Rapid and Completely Automated Real-time Reverse Transcriptase Polymerase Chain Reaction Assay for the Diagnosis of Enteroviral Meningits. J Clin Micro. 2011; 49:528-533.
    53. Romero JR. Rudolph's Pediatrics. Enterovirus Infections. 2011; 306.
    54. Stellrecht KA, Lamson DA, Romero JR. Entroviruses and parechoviruses. Manual of Clinical Microbiology. 2011; 1388-99.
    55. Romero JR, Stewart DL, Buysman EK, Fernandes AW, Jafri HS, Mahadevia PJ. Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants. Clin Ther. 2010 Dec; 32(14):2422-32. PMID: 21353110.
      View in: PubMed
    56. Stone RL, Sood AK, Coleman RL. Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer. Lancet Oncol. 2010 May; 11(5):465-75. PMID: 33766997.
      View in: PubMed
    57. Romero JR, O'Connor J. Pediatric Practice: Gastroenterology, Hepatology, and Nutrition. Viral Hepatitis. 2010.
    58. Juretschko SM, Romero JR, Harik N. Failur of Automated Identification Systems to Detect Methicillin Resistance of Staphylococcus aureus in Patients with Cystic Fibrosis. Infectious Diseases Society of America. 2010.
    59. Romero JR, Et al. Serious early childhood wheezing following respiratory syncytial virus lower respiratory tract infections in preterm infants. 2010.
    60. Romero J. Antimicrobial Therapy and Vaccines, Volume II. Enteroviruses (Coxsackieviruses, Echoviruses and Numbered Enteroviruses) and Parechoviruses. 2010.
    61. Carbonell-Estrany X, Simoes EAF, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA, Romero JR. Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. Pediatrics. 2010; 125:e35-e51.
    62. Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, Bradley JS, Wade K, Ramilo O, Romero JR, Shelton M, Leach C, Guzamn-Cottrill J, Robinson J, Abughali N, Englund J, Griffin J, Jester P, Cloud GA, Whitley RJ. Safety of oseltamivir vs. adamantanes in children under 12 months of age: A retrospective chart review. Pediatr Infect Dis J. 2010; 29:195-198.
    63. Romero JR, Stewart DL, Busyman EK, Fernandes AW, Jafri HS, Mahadevia PJ. Serious Early Childhood Wheezing Following Respiratory Syncytial Virus Lower Respiratory Tract Illness in Preterm Infants. Clin Ther. 2010; 32:2422-2432.
    64. Romero JR, Linam WM, Honeycutt M, Wisdom C. Clinical Characteristics of Infants <6 Months of Age Hospitalized with 2009 H1N1 Influenza Virus Infection. Pediatric Research. 2010.
    65. Romero JR, O'Connor J. Pediatric Practice: Gastroenterology. Viral Hepatitis. 2010; 24.
    66. Graham J, Shirm SW, Storm E, Linam WM, Romero JR. Impact of 2009 H1N1 Influenza on a Pediatric Emergency Department. Pediatric Research. 2010.
    67. Jurectschko S, Beavers-May TK, Hemphill C, Romero JR, Stovall SH. Superior Detection of Kingella kingae and Staphylococcus aureus in pediatric osteoarticular infections using molecular assays. 2009.
    68. Romero J. Textbook of Pediatric Infectious Diseases. West Nile virus infections. 2009; 188.
    69. Juretschko,SM, Romero JR, Harik,N. Failure of Automated Identification Systems to Detect Methicillin Resistance of Staphylococcus aureus in Patients with Cystic Fibrosis. 47th Annual Infectious Diseases Society of America Meeting. 2009.
    70. Romero JR. Clinical Virology. Enteroviruses. 2009; pp 1031-1062.
    71. Stewart D, Romero JR, Busyman E, Fernandes AW, Mahadevia PJ. Healthcare costs of preterm infants due to medically attended respiratory syncytial virus lower respiratory infection in the first year of life. Curr Med Res Opin. 2009; 25:2795-80.
    72. Newland JG, Romero J. The Encyclopedia of Public Health. Enteroviruses. 2008.
    73. Romero J. Group B Coxsackievirus Infections in Children. Curr Top Microbiol Immunol. 2008; 323:223-240.
    74. Stewart D, Romero J, Buysman EK, Fernandes AW, Mahadevia PJ. Total health care cost of preterm infants with medically attended respiratory syncytial virus lower respiratory tract infection. Infectious Diseases Society of America. 2008; 495 Abstract K - 1429.
    75. Witt D, Marcon M, Romero J, Sawyer M, Storch G, Dunn J, Schnurr D, Kok W. Multi-Center Evaluation of a Real Time NASBA Best for Detection of Enterovirus in Cerebrospinal Fluid From Pediatric Patients. 24th Annual Clinical Virology Symposium. 2008.
    76. Romero J, Varman M, Barton L. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Togaviruses. 2008.
    77. Romero J. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Arboviruses. 2008.
    78. Romero J, Simonsen KA. Powassan Encephalitis and Colorado Tick Fever. Infectious Diseases Clinics of North America. 2008; 22:545-559.
    79. Varman MV, Romero J, Cusick RA, Esposito PW, Armstrong D. Polymicrobial wound infection and nerve injury secondary to a non-human primate bite. Infect Med. 2008; 25:120-127.
    80. Newland JG, Romero J. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Myxoviruses. 2008.
    81. Romero J. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Orthopoxviruses. 2008.
    82. Truemper EJ, Romero J. West Nile virus. Pediatr Annals. 2007; 36:414-22.
    83. Jafri HS MD, Ramilo O, Makari D, Charsha-May D, Romero J. Diagnostic virology practices for respiratory syncytial virus (RSV) and influenza virus among children in the hospital setting: a nationa survey. Pediatr Infect Dis J. 2007; 26:956-58.
    84. Mix AC, Romero J. Comprehensive Pediatric Hospital Medicine. Central Nervous System Infections. 2007.
    85. Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM, Romero J. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007; 356:685-696.
    86. Newland JG, Romero J. Diagnosis fo viral encephalidites: Zoonotic-associated viruses. Concise Reviews in Pediatric Infectious Diseases, Pediatr Infect Dis J. 2006; 25(8):739-41.
    87. Herrera V, Babcock B, Bastola DR, Romero J, Gebhart C. Performance evaluation of an in-house enterovirus assay over a two year period. 22nd Annual Clinical Virology Symposium. 2006.
    88. Romero J. Manual of Clinical Microbiology. Entroviruses and parechoviruses. 2006.
    89. Ramilo O, Romero J, Jafri H, Makari D, Charsha-May D. Diagnostic testing for respiratory syncytial virus and influenza in the hospital setting: A national survey. American Academy of Pediatrics National Conference and Exhibition. 2005.
    90. Bastola DR, Romero J. Molecular epidemiology of Coxsackievirus B3 (CBV3) in the United States: 1949-1998. 24th Annual Meeting of the American Society for Virology. 2005; W27-8.
    91. Varman M, Romero J, Cornish NE, Manley J, Meza JL, Zach TL, Chartrand SA. Characterization and mechanisms of resistance of group B streptococcal isolates obtained at a community hospital. Euro J Clin Microbiol Infect Dis. 2005; 24:431-433.
    92. Romero J, Stacy RD. Minority Behavioral Risk Factor Survey in Douglas County: A Special Report to Nebraska Office of Minority Health. A Collaborative report with Douglas, Sarpy/Cass County, Nebraska Health Departments, Urban League of Nebraska, Chicano Awareness Center, University of Nebraska Medical Center, and University of Nebrask at Omaha. 2004; 1-34.
    93. Romero J, Cohen A, Boron M, Rankin M, Synagis Outcomes Registry Study Group. Respiratory Syncytial Virus (RSV) prophylaxis in minority populations; results from the Palivizumab Outcomes Registry 2002-2003. Pediatric Research. 2004; 237A.
    94. Newland JG, Romero J. Examination of the plasticity of the puff binding region of Coxsackievirus B3 (CVB3). American Academy of Pediatrics National Conference and Exhibition. 2004; Section on Residents.
    95. Romero J. Respiratory Syncytial Virus (RSV) prophylaxis in minority populations; results from the Palivizumab Outcomes Registry 2002-2003. 2004.
    96. Romero J, Ramilo O, Jafri H, Makari D, Charsha-May D. Diagnostic virology practices for respiratory syncytial virus (RSV) and influenza virus among children in the hospital setting: a national survey. Infectious Diseases Society of America. 2004; 129.
    97. Romero J. Experience with limited Phase I smallpox vaccination in a Midwestern children's hospital. 2004.
    98. Romero J, Allensworth CD, Pour AM. Experience with limited Phase I smallpox vaccination in a Midwestern children's hospital. Pediatric Research. 2004; 4.
    99. Romero J. Diagnostic virology practices for respiratory syncytial virus (RSV) and influenza virus among children in the hospital setting: a nationa survey. 2004.
    100. Romero J. Impact of PCR detection of evteroviral (EV) infection of the management of febrile neonates. 2003.
    101. Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero J. The stem loop II within the 5' nontranslated region of clinical Coxsackievirus B3 genomes determines cardiovirulence phenotype in murine model. J Infect Dis. 2003; 187:1552-1561.
    102. Romero J. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998-2002: Results from four years of palivizumab usage. Pediatr Infect Dis J. 2003; 22(2):Supp: 46-54.
    103. Varman M, Romero J, Cornish NE, Yam PA. Time to detection of respiratory viruses using meixed cell shell vial cultures: 2 vs. 5 days. 41st Annual Infectious Diseases Society of America Meeting, Program and Abstracts. 2003; 92.
    104. Newland JG, Romero J, Varman M, Drake C, Holst A, Safranek T, Subbarao K. Encephalitis associated with influenza B infection in two children and a review of the literature. Clin Infect Dis. 2003; 36:e87-95.
    105. Romero J, Allensworth C, Pour AM. Evaluation of phase I vaccination in Douglas County, Nebraska. Infectious Diseases Society of America. 2003; 173.
    106. Newland JG, Romero J, Sarica A, Lych JC. Impact of PCR detection of evteroviral (EV) infection of the management of febrile neonates. Pediatric Research. 2003; 4.
    107. Romero J, Newland JG. Viral Meningitis and Encephalitis: Traditional and emerging viral agents. Semin Pediatr Infect Dis. 2003; 14:72-82.
    108. Romero J, Rotbart HA. Manual of Clinical Microbiology. Enteroviruses. 2003.
    109. Romero J, Kimberlin DW. Molecular diagnosis of viral infections of the central nervous system. Clin Lab Med. 2003; 23:843-865.
    110. Abzug MJ, Cloud G, Bradley J, Sánchez P, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberly DW, Collaborative Antiviral Study Group. Double blind, placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003; 22(4):335-341.
    111. Romero J. Spectrum of neonatal enteroviral disease over an 8-year period. 2002.
    112. Gangitano M, Valero-Cabré A, Tormos JM, Mottaghy FM, Romero JR, Pascual-Leone A. Modulation of input-output curves by low and high frequency repetitive transcranial magnetic stimulation of the motor cortex. Clin Neurophysiol. 2002 Aug; 113(8):1249-57. PMID: 12140004.
      View in: PubMed
    113. Romero J. Changing susceptibility of group B Streptococcus from a community hospital in a mid-sized Midwestern city. 2002.
    114. Romero J. Diagnosis and management of enteroviral infections of the central nervous system. Curr Infect Dis Rep. 2002; 4:309-316.
    115. Romero J, Newland JG. Antimicrobial Therapy and Vaccines. Enteroviruses (Polioviruses, coxsackieviruses, echoviruses and numbered enteroviruses). 2002.
    116. Varman M, Cornish NE, Zach TL, Romero J. Changing susceptibility of group B Streptococcus from a community hospital in a mid-sized Midwestern city. Pediatric Research. 2002.
    117. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero J, Leser JS. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: Inoculating NOD mice with CVB markedly lowers diabetes incidence. J Virol. 2002; 76(23):12097-12111.
    118. Romero JR, Anschel D, Sparing R, Gangitano M, Pascual-Leone A. Subthreshold low frequency repetitive transcranial magnetic stimulation selectively decreases facilitation in the motor cortex. Clin Neurophysiol. 2002 Jan; 113(1):101-7. PMID: 11801430.
      View in: PubMed
    119. Newland JG, Romero J, Sarica A, Zach TL, Linder K. Spectrum of neonatal enteroviral disease over an 8-year period. Infectious Diseases Society of America. 2002; 50.
    120. Romero J. Molecular epidemiology of coxsackievirus B3 in the United States: 1949-1998. 2001.
    121. Rotbart HA, Webster AD, Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus with pleconaril. Clin Infect Dis. 2001; 32:228-235.
    122. Boyd ZS, Bradrick SS, Cornish N, Carden BM, Romero J. Mutations within the IRES of echovirus 12 confer a novel pathogenic phenotype to and echovirus 12-coxsackeivirus B3 chimera. 30th Annual Meeting of the American Society for Virology. 2001.
    123. Romero J. Pleconaril: A novel antipicornaviral drug. Exp Opin Investig Drugs. 2001; 10(2):369-379.
    124. Bradrick SS, Romero J. Polioviruses. 2001; 1-7.
    125. Willis TMS, Hopp RJ, Romero J, Larsen PD. The protective effect of brachial plexus palsy in Purpura fulminans. Pediatr Neurol. 2001; 24(5):379-381.
    126. Newland JG, Romero J, Subbarao K, Safranek T. Encephalitis associated with influenza B infections: A case series in children. Infectious Diseases Society of America. 2001; 66.
    127. Romero J. Mutations within the IRES of echovirus 12 confer a novel pathogenic phenotype to and echovirus 12-coxsackeivirus B3 chimera. 2001.
    128. Kimberlin DW, Lin CY, Jacobs RF, Et al.,. Natural history of neonatal herpes simplex virus infections. Pediatrics. 2001; 108(2004):223-229.
    129. Parasuraman TV, Frenia K, Romero JR. Enteroviral meningitis: Cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics. 2001; 19(1990):3-12.
    130. Romero J. Encephalitis associated with influenza B infections: A case series in children. 2001.
    131. Romero J. Enteroviruses in humans. 2001; 1-7.
    132. Bradrick SS, Lieben EA, Carden BM, Romero J. A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell type specific block to viral replication. J Virol. 2001; 75(14):6472-6481.
    133. Romero J. Further mapping of the coxsackievirus B3 (CVB3) 5' nontranslated region (5'NTR) cardiovirulence determinant. 2000.
    134. Romero J. Identification of the major determinant of cardiovirulence of coxsackievirus B3. 2000.
    135. Parasuraman TV, Deverka PA, Toscini MR, Meningitis Consensus Panel. Estimating the economic impact of viral meningitis in the United States. Infect Med. 2000; 17:417-427.
    136. Dunn JJ, Romero J, Wasserman R, Rotbart HA. Stable enterovirus genome over a seven-year period in a patient with agammaglobulinemia and chronic infection. J Infect Dis. 2000; 182:298-301.
    137. Bradrick SS, Carden BM, Dunn JJ, Romero J. Further mapping of the coxsackievirus B3 (CVB3) 5' nontranslated region (5'NTR) cardiovirulence determinant. 29th Annual Meeting of the American Society for Virology. 2000.
    138. Willian S, Tracy S, Chapman N, Leser S, Romero J, Shapiro B, Currey K. Mutations in a conserved enteroviral RNA oligonucleotide sequences affect positive strand viral RNA synthesis. Arch Virol. 2000; 145(10):2061-2086.
    139. Romero J, Tracy SM, Chapman NM, Dunn JJ. Identification of the major determinant of cardiovirulence of coxsackievirus B3. Pediatric Research. 2000.
    140. Dunn JJ, Chapman N, Tracy S, Romero J. Genomic determinants of cardiovirulence in coxackievirus B3 clinical isolates: Localizaion to the 5' nontranslated region. J Virol. 2000; 74:4787-4794.
    141. Romero J. Coxsackievirus B3 (CVB3) genotypes in the United States (US). 1999.
    142. Romero J. Molecular epidemiology of coxsackievirus B3 (CVB3) in the United States--1954-1979. 1999.
    143. Romero J. Cardiovirulence determinants among naturally occurring isolates of coxsackievirus B3 reside within the 5' nontranslated region. 1999.
    144. Romero J. Pleconaril treatment of vaccine-acquired poliovirus. 1999.
    145. Modlin J, Reiss M, Romero J, Et al. Development and validation of a decision analytic framework to evaluate the economic impact of suspected meningitis. Internationa Society for Pharmacoeconomics and Outcomes Research Meeting. 1999.
    146. Modlin J, Reiss M, Romero J. Estimating the economic impact of viral meningitis in the United States. Internationa Society for Pharmacoeconomics and Outcomes Research Meeting. 1999.
    147. Dunn JJ, Tracy SM, Chapman NM, Romero J. Deteminants of cardiovirulence in coxsackievirus B3 (CVB3) clinical isolates localize to the 5' nontranslated regions (5'NTR). 18th Annual Meeting of the American Society for Virology. 1999.
    148. Modlin J, Reiss M, Romero J, Et al. Estimating the economic impact of viral meningitis in the United States. Internationa Society for Pharmacoeconomics and Outcomes Research Meeting. 1999.
    149. Sawyer MH, Saez-Llorenz X, Aviles CL, O'Ryan M, Romero J. Oral Pleconaril reduces the duration and severity of enteroviral meningitis in children. Pediatric Research. 1999.
    150. Romero J, Gross T, Abromowitch M, Jung L. Pleconaril treatment of vaccine-acquired poliovirus. Pediatric Research. 1999.
    151. Bradrick SS, Lieben EA, Romero J. Nonreceptor determinants of growth restriction reside within the echovirus 12 5' nontranslated region. 18th Annual Meeting of the American Society for Virology. 1999.
    152. Romero J. Reverse transcription-polymerase chain reaction detection of the enteroviruses: Overview and clinical utility in pediatric enteroviral infections. Arch Pathol Lab Med. 1999; 123:1161-1169.
    153. Romero J, Dunn JJ, Tracy SM, Et al. Cardiovirulence determinants among naturally occurring isolates of coxsackievirus B3 reside within the 5' nontranslated region. Pediatric Research. 1999.
    154. Romero J. Enteroviruses: Diagnosis, screening, and surveillance. Infect Med. 1999; 16(Suppl D ):11-20.
    155. Heuermann KG, Romero J, Abromowitch MA, Gordon BG, Gross TG. Fatal coagulase negative staphylococci infection after bone marrow transplantation in a patient with persistent adverse reactions to vancomycin. Am J Pediatr Hematol/Oncol. 1999; 21:80-81.
    156. Romero J, Schnurr D, Oberste MS, Bradrick SS, Et al. Molecular epidemiology of coxsackievirus B3 (CVB3) in the United States--1954-1979. 18th Annual Meeting of the American Society for Virology. 1999.
    157. Romero J, Bradrick SS, Schnurr D, Oberste S, Et al. Coxsackievirus B3 (CVB3) genotypes in the United States (US). Infectious Diseases Society of America. 1999; 164.
    158. Romero J. Molecular and phenotypic characterization of a myocarditic coxsackievirus B3 (CVB3) isolate. 1998.
    159. Romero J. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children results in reduced health care expenditures. 1998.
    160. Romero J. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children reduces duration of hospitalization, antibiotic administration and results in reduced health care costs. 1998.
    161. Romero J. Impact of reverse transcription-polymerase chain reaction diagnosis of enterovirus infections on the care of febrile children. 1998.
    162. Romero J, Kirk C, Dunn J, Et al. Molecular and phenotypic characterization of a myocarditic coxsackievirus B3 (CVB3) isolate. Infectious Diseases Society of America. 1998; 134.
    163. Romero J, Hinrichs S, Perry D, Kruger R, Magelli M. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children reduces duration of hospitalization, antibiotic administration and results in reduced health care costs. 15th Annual Meeting of the Minority Medical Faculty Development Program. 1998.
    164. Romero J, Bures E, Bradrick S, Price C. Molecular epidemiology of coxsackievirus B3 in the United States: 1949-1998. Pediatric Research. 1998.
    165. Dunn JJ, Tracy SM, Romero J. The 5' untranslated region (5' UTR) of a wild-type coxsackievirus B3 (CBV3) strain attenuates the cardiovirulent phenotype of CBV3/20. 17th Annual American Society for Virology Scientific Program. 1998.
    166. Romero J, Hinrichs S, Perry D, Et al. Impact of reverse transcription-polymerase chain reaction diagnosis of enterovirus infections on the care of febrile children. Pediatric Research. 1998.
    167. Rotbart HA, Brennan PJ, Fife KH, Romero J, Et al. Enterovirus meninigitis in adults. Clin Infect Dis. 1998; 27(4):896-898.
    168. Romero J, Magelli M, Hinrichs S, Et al. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children results in reduced health care expenditures. Infectious Diseases Society of America. 1998; 201.
    169. Boken DJ, Romero J, Cavalieri SJ. Sphingomonas paucimobilis bacteremia: Four cases and review of the literature. Infect Dis Clin Prac. 1998; 7:286-291.
    170. Romero J. Complete capsid amino acid sequences of 14 wild-type coxsackievirus B3 (CBV3) isolates. 1997.
    171. Romero J. Echovirus-coxsackievirus chimeras for the evaluation of the role of the echovirus 5' nontranslated region (5' NTR) in pathogenesis. 1997.
    172. Romero J, Dunn JJ, Leser JS, Et al. Complete capsid amino acid sequences of 14 wild-type coxsackievirus B3 (CBV3) isolates. 16th Annual American Society for Virology Scientific Program and Abstracts. 1997.
    173. Romero J, Price C, Dunn JJ. Genetic divergence among the group B coxsackieviruses. Curr Top Microbiol Immunol. 1997; 223:81-96.
    174. Chapman NM, Romero J, Pallansch MA, Tracy S. Sites other than nucleotide 234 determin cardiovirulence in natural isolates of coxsackievirus B3. J Med Virol. 1997; 52:258-261.
    175. Romero J, Lieben E, Tracy SM, Et al. Echovirus-coxsackievirus chimeras for the evaluation of the role of the echovirus 5' nontranslated region (5' NTR) in pathogenesis. Pediatric Research. 1997.
    176. Romero J. Genetic diversity and molecular epidemiology among coxsackievirus B2 (CVB2) during a community outbreak. 1996.
    177. Romero J. Potential health care cost savings from PCR-based rapid diagnosis of enteroviral meningitis. 1996.
    178. Tracy S, Chapman NM, Romero J, Ramsingh AI. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol. 1996.
    179. Ehrhardt AF, Sanders CC, Romero J, Leser JS. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob Agents Chemother. 1996; 40(8):1953-1956.
    180. Romero J, Tracy SM, Pong AL, Hinrichs SH, Leser JS. Genetic diversity and molecular epidemiology among coxsackievirus B2 (CVB2) during a community outbreak. Pediatric Research. 1996.
    181. Romero J, Hinrichs SH, Cavalieri SJ, Perry D, Leser JS, Onyeuku J. Potential health care cost savings from PCR-based rapid diagnosis of enteroviral meningitis. Pediatric Research. 1996.
    182. Rotbart HA, Brennan PJ, Fife KH, Romero J, Et al. Enterovirus (EV) meningitis (M) in adults. 36th Interscience Conference on Antimicrobials Agents and Chemotherapy Abstracts. 1996.
    183. Tracy S, Chapman N, Romero J, Currey K, Shapiro B. Mutations at position 234 in coxsackieviral 5' NTR. 15th Annual American Society for Virology Scientific Program and Abstracts. 1996.
    184. Romero J, Tracy SM, Chapman NM, Leser JS. Chimeric coxsackievirus B3 as a vehicle to study the echovirus 5' nontranslated region (5'NTR). 15th Annual American Society for Virology Scientific Program and Abstracts. 1996.
    185. Tracy S, Chapman N, Ramsingh A, Romero J, Curry K, Shapiro B, Barry W, Chin T, Hufnagel G. The Role of Immune Mechanisms in Disease. Coxsackievirus genetics and the cardiovirulent viral phenotype. 1996.
    186. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero J, Barry WH, Zhao L, Curry K, Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol. 1995; 69(8):4607-4618.
    187. Ehrhardt A, Sanders C, Romero J, Leser J. Sequencing and analysis of four new Enterobacter ampD alleles. Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995.
    188. Rotbart HA, Romero J. Human Enterovirus Infections. Laboratory diagnosis of enterovirus infections. 1995.
    189. Romero J, Rotbart HA. Sequence analysis of the downstream 5' nontranslated region of seven echoviruses with different neurovirulence phenotypes. J Virol. 1995; 69:1370-1375.
    190. Chapman N, Tu Z, Hufnagel G, Tracy S, Romero J, Barry W, Zhao L, Currey K. Determination of genetics and mechanism of coxsackievirus B3 cardiovirulence. 95th General Meeting of American Society for Microbiology. 1995.
    191. Romero J, Leser JS, Tracy S, Chapman N, Winters D. Amino acid sequence variation in the major surface loop (VP2 E-F) of the cell receptor site from 8 clinical isolates of coxsackievirus B3. Pediatric Research. 1995.
    192. Romero J, Ogle JW. Arboviral infections in the US: Encephalitis, Colorado tick fever and hantavirus. Seminars in Pediatric Infectious Diseases. 1994; 5:95-101.
    193. Levin MJ, Romero J. Current Pediatric Diagnosis and Treatment. Infections: Viral and Rickettsial. 1994.
    194. Romero J, Rotbart HA. PCR- Based Diagnostics of Infectious Organisms. Polymerase chain reaction strategies for the detection of the human enteroviruses. 1994.
    195. Romero J. Pediatric tuberculosis. Current Opinion in Infectious Diseases. 1994; 7:374-381.
    196. Romero J, Tracy S, Chapman N, Gauntt C. Genetic variation in coxsackievirus B3 genomes. 13th Annual American Society for Virology Scientific Program and Abstracts. 1994.
    197. Romero J. Genomic Variation of Coxsackievirus B3. 1994.
    198. Romero J, Rotbart HA. Sequence diversity among enteroviruses with different neurovirulence phenotypes. Pediatric Research. 1993.
    199. Romero J. Sequence diversity among enteroviruses with different neurovirulence phenotypes. 1993.
    200. Romero J, Rotbart HA. Selective amplification and partial sequence analysis of the 5'NTR of seven enteroviruses with different neurovirulence phenotypes. 12th Annual American Society for Virology Scientific Program and Abstracts. 1993.
    201. Romero J, Rotbart HA. Selective amplification and partial sequence analysis of the 5'NTR of seven enteroviruses with different neurovirulence phenotypes. 1993.
    202. Romero J. Tick-borne diseases of the United States. Contagious Comments. 1992; 12:1-5.
    203. Romero J. Tick-borne diseases of the United States- Update 1992. 1992.
    204. Doski JJ, Priebe CJ Jr., Driessnak-Hill M, Smith T, Kane P, Romero J. Corticosteroids in management of unresectable plasma cell granuloma (inflammatory psudeotumor) of the lung. J Pediatr Surg. 1991; 26:1064.
    205. Biancaniello TM, Romero J. Bacterial endocarditis after adjustment of orthodontic appliances. J Pediatr. 1991; 118:248.
    206. Romero J, Rotbart HA. Discriminant enteroviral replication in U937 cells: a candidate model for monocyte/enterovirus interactions. 1990.
    207. Romero J, Rotbart HA. Discriminant enteroviral replication in U937 cells: a candidate model for monocyte/enterovirus interactions. 30th Interscience Conference on Antimicrobial Agents and Chemotherapy Program and Abstracts. 1990.
    208. Romero J, Putnak R, Wimmer E. Enteroviral capsid protein VP3 as a group antigen for the enteroviruses. 1988.
    209. Romero J, Putnak R, Wimmer E. Enteroviral capsid protein VP3 as a group antigen for the enteroviruses. Pediatric Research. 1988.
    210. Wimmer E, Kuhn RJ, Toyoda H, Nicklin MJH, Diamond DC, Murray MG, Romero J. Chemical and biologic properties of the poliovirion. Biologic Chem. 1986.
    211. Romero J, Putnak R, Wimmer E. The use of poliovirus proteins VP3 and 2C as group antigens for the detection of enteroviral infections by indirect immunofluorescence. Poster session presented. 1986.
    212. Romero J, Putnak R, Wimmer E. The use of poliovirus proteins VP3 and 2C as group antigens for the detection of enteroviral infections by indirect immunofluorescence. Pediatric Research. 1986.
    Romero's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description